HIMS & HERS HEALTH INC (HIMS) Stock Analyst Earnings Estimates
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 526.916M 93.81% | 872M 65.49% | 1.477B 69.33% | 2.315B 56.79% | 2.734B 18.10% | 3.472B 26.99% | 3.118B -10.20% | 3.526B 13.09% | 3.92B 11.17% | 4.344B 10.82% | 4.797B 10.43% | |
| EBITDA YoY % growth | -58.904M 39.67% | -16.493M 72.00% | 85.092M 615.93% | 261.32M 207.10% | 321.09M 22.87% | 356.75M 11.11% | 472.87M 32.55% | 466.55M -1.34% | 534.38M 14.54% | 609.55M 14.07% | 692.38M 13.59% | |
| EBIT YoY % growth | -66.378M 34.74% | -26.008M 60.82% | 68.004M 361.47% | 141.3M 107.78% | 181.05M 28.13% | 241.15M 33.20% | 334.46M 38.69% | 340.68M 1.86% | 450.84M 32.34% | 561M 24.43% | N/A | |
| Operating Margin | -12.60% | -2.98% | 4.61% | 6.10% | 6.62% | 6.95% | 10.73% | 9.66% | 11.50% | 12.91% | N/A | |
| EPS YoY % growth | -0.32 42.75% | -0.11 65.63% | 0.54 590.91% | 0.52 -4.34% | 0.70 36.45% | 1.31 85.96% | 1.46 11.28% | 1.71 17.48% | 1.99 16.07% | 2.31 15.90% | 2.65 15.04% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.12 144.80% | 0.15 151.60% | 0.18 -42.63% | 0.20 84.53% | 0.30 147.22% | 0.32 111.71% | 0.31 68.52% | 0.28 39.03% | 0.40 33.14% | 0.43 34.04% | 0.40 28.57% | 0.34 21.08% |
| Revenue Q2Q % growth | 540.48M 94.30% | 571.22M 80.97% | 584.59M 45.58% | 626.23M 30.16% | 627.86M 16.17% | 653.07M 14.33% | 677.55M 15.90% | 708.65M 13.16% | 749.87M 19.43% | 786.89M 20.49% | 823.23M 21.50% | 854.29M 20.55% |
| EBITDA Q2Q % growth | 61.486M 376.49% | 70.822M 286.94% | 79.294M 131.45% | 86.468M 117.00% | 90.104M 46.54% | 96.528M 36.30% | 95.157M 20.01% | 93.803M 8.48% | 124.25M 37.90% | 129.98M 34.66% | 124.05M 30.36% | 112.68M 20.12% |
| EBIT Q2Q % growth | 35.353M 256.99% | 43.896M 276.50% | 55.499M 138.89% | 62.098M 172.85% | 72.688M 105.61% | 77.768M 77.16% | 71.63M 29.07% | 61.466M -1.02% | 90.779M 24.89% | 96.465M 24.04% | 90.587M 26.47% | 79.162M 28.79% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.11 1,000.00% | 0.11 | 0.00 | 4.62% |
| Q3 2024 Q2Q % growth | 0.32 900.00% | 0.04 | 0.28 | 666.87% |
| Q2 2024 Q2Q % growth | 0.06 300.00% | 0.04 | 0.02 | 37.66% |
| Q1 2024 Q2Q % growth | 0.05 200.00% | 0.01 | 0.04 | 308.50% |
| Q4 2023 Q2Q % growth | 0.01 120.00% | -0.02 | 0.03 | 152.29% |
| Q3 2023 Q2Q % growth | -0.04 55.56% | -0.03 | -0.01 | -24.77% |
| Q2 2023 Q2Q % growth | -0.03 70.00% | -0.06 | 0.03 | 45.82% |
| Q1 2023 Q2Q % growth | -0.05 37.50% | -0.07 | 0.02 | 31.37% |
| Q4 2022 Q2Q % growth | -0.05 66.67% | -0.07 | 0.02 | 26.47% |
| Q3 2022 Q2Q % growth | -0.09 -13.92% | -0.10 | 0.01 | 13.49% |
| Q2 2022 Q2Q % growth | -0.10 -233.33% | -0.10 | 0.00 | 3.57% |
| Q1 2022 Q2Q % growth | -0.08 73.33% | -0.07 | -0.01 | -10.08% |
| Q4 2021 Q2Q % growth | -0.15 -114.29% | -0.07 | -0.08 | -102.84% |
| Q3 2021 Q2Q % growth | -0.08 | -0.06 | -0.02 | -25.59% |
| Q2 2021 Q2Q % growth | -0.03 | -0.08 | 0.05 | 64.24% |
| Q1 2021 Q2Q % growth | -0.30 | -0.11 | -0.19 | -180.78% |
| Q4 2020 Q2Q % growth | -0.07 | -0.16 | 0.09 | 57.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 481.139M 95.45% | 479.72M | 1.419M | 0.30% |
| Q3 2024 Q2Q % growth | 401.556M 77.13% | 389.85M | 11.706M | 3.00% |
| Q2 2024 Q2Q % growth | 315.648M 51.82% | 305.94M | 9.708M | 3.17% |
| Q1 2024 Q2Q % growth | 278.171M 45.81% | 275.79M | 2.381M | 0.86% |
| Q4 2023 Q2Q % growth | 246.169M 47.23% | 251.38M | -5.211M | -2.07% |
| Q3 2023 Q2Q % growth | 226.699M 56.52% | 224.45M | 2.249M | 1.00% |
| Q2 2023 Q2Q % growth | 207.912M 83.08% | 209.06M | -1.148M | -0.55% |
| Q1 2023 Q2Q % growth | 190.77M 88.30% | 182.66M | 8.11M | 4.44% |
| Q4 2022 Q2Q % growth | 167.203M 97.41% | 164.39M | 2.813M | 1.71% |
| Q3 2022 Q2Q % growth | 144.836M 95.27% | 132.95M | 11.886M | 8.94% |
| Q2 2022 Q2Q % growth | 113.563M 87.11% | 105.96M | 7.603M | 7.18% |
| Q1 2022 Q2Q % growth | 101.314M 93.67% | 92.998M | 8.316M | 8.94% |
| Q4 2021 Q2Q % growth | 84.699M | 78.329M | 6.37M | 8.13% |
| Q3 2021 Q2Q % growth | 74.173M | 71.942M | 2.231M | 3.10% |
| Q2 2021 Q2Q % growth | 60.692M | 57.623M | 3.069M | 5.33% |
| Q1 2021 Q2Q % growth | 52.314M | 49.79M | 2.524M | 5.07% |
| Q4 2020 Q2Q % growth | 37.744M | -37.744M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.27% | -8.86% | 0.28% | 1.84% |
| Revenue | 6.84% | 6.52% | 0% | 1.84% |